Cervical cancer screening can now include “self-swab” HPV tests, according to updated guidelines published Thursday by the American Cancer Society. The change, experts hope, will encourage more women ...
SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science ...
The American Cancer Society has endorsed self-collected vaginal samples for cervical cancer screening — a change medical experts say will help expand access and improve detection. The updated ACS ...
DARE-HPV is a proposed treatment for HPV-related cervical diseases, supported by up to $2 million in NIAID grants. Daré Bioscience, Inc. has announced the development of DARE-HPV, an investigational ...
Recurrent Respiratory Papillomatosis (RRP), a challenging condition caused primarily by HPV-6 and HPV-11, is characterized by benign but relentless growths in the airway. While the anti-angiogenic ...
SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Dare´ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results